Manufacturer record
Globela Pharma Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Globela Pharma Pvt. Ltd (Gujarat) were declared Not of Standard Quality between January 2020 and August 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GT23026, DICLOGLOBE 50 (Diclofenac Sodium Tablets I.P. 50 mg) (exp Dec 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Disintegration. Listed in the August 2023 alert.
Records by type
3 records linked to Globela Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| DICLOGLOBE 50 (Diclofenac Sodium Tablets I.P. 50 mg) | Batch GT23026Mfg Jan 2023 · Exp Dec 2025 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Aug 2023 |
| Oral Rehydration Salts IP | Batch GP19127Mfg Feb 2019 · Exp Jan 2022 | Assay for PotassiumAssay | CDTL MumbaiCDSCO lab | Jan 2020 |
| Oral Rehydration Salts IP | Batch GP19128Mfg Feb 2019 · Exp Jan 2022 | Assay for PotassiumAssay | CDTL MumbaiState lab | Jan 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.